Matches in Wikidata for { <http://www.wikidata.org/entity/Q104674954> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q104674954 description "clinical trial" @default.
- Q104674954 description "ensayo clínico" @default.
- Q104674954 description "ensayu clínicu" @default.
- Q104674954 description "klinisch onderzoek" @default.
- Q104674954 description "клінічне випробування" @default.
- Q104674954 description "临床试验" @default.
- Q104674954 name "Olaparib in Combination With Pembrolizumab and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma" @default.
- Q104674954 name "Olaparib in Combination With Pembrolizumab and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma" @default.
- Q104674954 type Item @default.
- Q104674954 label "Olaparib in Combination With Pembrolizumab and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma" @default.
- Q104674954 label "Olaparib in Combination With Pembrolizumab and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma" @default.
- Q104674954 prefLabel "Olaparib in Combination With Pembrolizumab and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma" @default.
- Q104674954 prefLabel "Olaparib in Combination With Pembrolizumab and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma" @default.
- Q104674954 P1050 Q104674954-1B4B41AC-B714-4264-A4B2-77B60DEE36CC @default.
- Q104674954 P1132 Q104674954-B121C34D-0A96-40F1-A486-158DC0DF6D88 @default.
- Q104674954 P1476 Q104674954-C8589720-6EE5-4BC9-A6CD-6B99718FE25C @default.
- Q104674954 P17 Q104674954-D38F693B-B9C5-409A-BC9D-3C1E5693173C @default.
- Q104674954 P2899 Q104674954-D7C683A9-83E1-4054-8AC5-CAB294E97BCF @default.
- Q104674954 P3098 Q104674954-8B14AC02-3645-4CB3-978A-3ADA6637402B @default.
- Q104674954 P31 Q104674954-FD9B5752-1541-4D79-B4D6-608421242A72 @default.
- Q104674954 P4844 Q104674954-6AD95727-4CFB-4636-B646-5FA018F3DCED @default.
- Q104674954 P4844 Q104674954-77D468FE-DE65-4B20-8A60-C4262D51EC67 @default.
- Q104674954 P4844 Q104674954-A508C6F7-13A0-4A6F-9ACA-F1BF288B21C3 @default.
- Q104674954 P580 Q104674954-370D3CED-C1EA-442D-8073-EB3ED13193F4 @default.
- Q104674954 P582 Q104674954-5B53F42D-C378-4760-B23C-FF3D52D85CC2 @default.
- Q104674954 P6099 Q104674954-62288A31-6CA3-486D-ADAB-8BFABE8973E2 @default.
- Q104674954 P6153 Q104674954-07938BA9-DFC8-4CAE-A66E-545AFAD389E8 @default.
- Q104674954 P767 Q104674954-D773B825-EB8D-4DA8-A2C9-BC9B07DB3F1A @default.
- Q104674954 P8005 Q104674954-A96ECC9C-A9DC-45B7-BFF2-5D47E65EAF69 @default.
- Q104674954 P8363 Q104674954-6644AF84-DC62-4356-9A06-B4CC59F0317B @default.
- Q104674954 P859 Q104674954-194EE509-99DE-4A00-8B9F-48622ECDDC5E @default.
- Q104674954 P1050 Q33525 @default.
- Q104674954 P1132 "+29" @default.
- Q104674954 P1476 "Olaparib in Combination With Pembrolizumab and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma: A Single-Arm, Phase 2 Trial" @default.
- Q104674954 P17 Q30 @default.
- Q104674954 P2899 "+18" @default.
- Q104674954 P3098 "NCT04643379" @default.
- Q104674954 P31 Q30612 @default.
- Q104674954 P4844 Q13896859 @default.
- Q104674954 P4844 Q415588 @default.
- Q104674954 P4844 Q7083106 @default.
- Q104674954 P580 "2021-01-31T00:00:00Z" @default.
- Q104674954 P582 "2024-01-31T00:00:00Z" @default.
- Q104674954 P6099 Q42824440 @default.
- Q104674954 P6153 Q7972509 @default.
- Q104674954 P767 Q58219685 @default.
- Q104674954 P8005 Q76649614 @default.
- Q104674954 P8363 Q78089383 @default.
- Q104674954 P859 Q7972509 @default.